GILD Stock Down on Report of Cut in HIV Prevention Spending
Gilead Sciences takes a hit after a Wall Street Journal reports state that the Trump administration is looking to slash ...
Oppenheimer doesn’t see threat to Gilead estimates after HHS plans for HIV cuts
Oppenheimer notes that Gilead (GILD) shares are weak today following reports from multiple media outlets that the Health and Human Services department is mulling cuts to federal HIV prevention funding ...
STAT12h
Biotech stocks get boost from Fed rate outlook
The Fed kept rates unchanged for now, a move that was widely expected. It did note, though, that “uncertainty around the ...
Stocktwits on MSN22h
Gilead Stock Wobbles On Federal HIV Funding Cut Buzz, But Retail And Analysts Stay Unfazed
Shares of Gilead Sciences, Inc. dropped nearly 2.5% on Wednesday and extended losses after hours following a report that the ...
Health Care Roundup: Market Talk
Find insight on Gilead Sciences, Sarepta Therapeutics and more in the latest Market Talks covering the health care sector.
The American Journal of Managed Care13h
Elimination of HIV Prevention Division Being Considered by Trump Administration
The HIV prevention division could be rolled into another department of the HHS as soon as the end of the week.